Page 240 - Eshre Final Programme 2015

P-490 Anti Mullerian Hormone (AMH) co-treatment to prevent chemotherapy-induced follicle activation and loss
H. Roness1, S. Derekh-Haim1, Z. Gavish1, N. Sioni1, D. Meirow1
1Chaim Sheba Medical Center, Center for Fertility Preservation, Ramat Gan, Israel
P-491 Safety of cryopreserved ovarian tissue autotransplantation in leukaemia patients
R. Fabbri1, M. Macciocca1, R. Vicenti1, P.P. Piccaluga2, E. Sabattini2, A. Gazzola2, C. Mannu2, R. Paradisi1, S. Rossi1
1Gynecology and Pathophysiology of Human Reproduction Unit S. Orsola-Malpighi Hospital University of Bologna, Department of Medical and Surgical Sciences, Bologna, Italy
2Hematopathology Section S. Orsola-Malpighi Hospital University of Bologna, Department of Experimental Diagnostic and Specialty Medicine, Bologna, Italy
P-492 The influence of pregnancy on the prognosis of endometrial atypical hyperplasia and adenocarcinoma with assisted reproductive technology after fertility-sparing therapy: a systematic review and meta-analysis
L.P. Yu1, S.Y. Zhao1, H. Chao1, Y. Liu*1
1Beijing Obstetrics and Gynecology Hospital Capital Medical University, Department of Reproductive Medicine, Beijing, China
240